Table 2.
Targeted Phasing Results Summary
Sample | Chr | Targeted Phasing Region | Belonged Phase block | Phase Block Length | Contained Heterozygous SNPs |
---|---|---|---|---|---|
G2018004A_LYL | 16 | 215,400–234,700 | 132,167–542,445 | 410.2 kb | 309 |
G2018004B_LGB | 16 | 215,400–234,700 | 223,804–543,224 | 319.4 kb | 251 |
G2018001A_LSL | X | 43,817,770 | 43,752,981–44,015,286 | 262.3 kb | 134 |
SNPs Single nucleotide polymorphisms
Targeted phasing region, the pathogenic mutation sites for respective samples; Belonged Phase block, the phase block that contained the mutation sites